FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutics and concerns use of carrier vehicle for enteral application of biologically active substances containing effective amount of one or more phosphate derivatives of one or more electronically carried agents.
EFFECT: invention allows for higher effectiveness and improved transport of enterally introduced biologically active compounds.
18 cl, 2 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSPORTING FILLER, WHICH CONTAINS ONE OR MORE DI- AND/OR MONO-(ELECTRONIC TRANSMITTING AGENT) PHOSPHATE DERIVATIVES OR THEIR COMPOUNDS | 2006 |
|
RU2434643C2 |
| ALKALOID FORMULATIONS | 2005 |
|
RU2477136C2 |
| COMPOSITIONS WHICH POISSESS LIPID-REDUCING PROPERTIES | 2006 |
|
RU2428973C2 |
| COMPOSITIONS POSSESSING ANTI-CANCIROGENIC PROPERTIES | 2006 |
|
RU2435580C2 |
| CARRIER COMPOSITION | 2010 |
|
RU2577233C2 |
| CONTROLLED RELEASE OF PHENOL OPIATE | 2007 |
|
RU2469038C2 |
| SYNTHETIC ANALGESIC MEANS OF PEPTIDE NATURE AND METHOD OF ITS USE | 2017 |
|
RU2656188C1 |
| PHARMACEUTICAL COMPOSITION FOR CANCER AND VIRAL DISEASE TREATMENT, METHOD OF CANCER TREATMENT, METHOD OF VIRAL INFECTION TREATMENT BASED ON THEREOF | 1996 |
|
RU2177316C2 |
| ALBUMIN-BINDING PRODRUGS BASED ON AURISTATIN E DERIVATIVES | 2018 |
|
RU2795101C2 |
| COMPOSITION AND METHOD FOR PRODUCING PEPTIDE ANALGETIC AGENT | 2017 |
|
RU2669386C1 |
